トルマブ150mg注射剤

トルマブ 150mg Injection is a medication used to treat certain types of cancer and autoimmune diseases. Its active ingredient is Tocilizumab, a humanized monoclonal antibody that targets the interleukin-6 (IL-6) receptor. IL-6 is a cytokine that plays a significant role in inflammation and immune responses. By blocking the action of IL-6, トルマブ helps to reduce inflammation and suppress the overactive immune system.

This medication is indicated for the treatment of conditions such as rheumatoid arthritis, systemic juvenile idiopathic arthritis, giant cell arteritis, and cytokine release syndrome associated with chimeric antigen receptor T-cell therapy. It is administered via subcutaneous injection by a healthcare professional.

Common side effects may include upper respiratory tract infections, headache, dizziness, and injection site reactions. Serious side effects, though less common, can include severe infections, gastrointestinal perforations, and hypersensitivity reactions. Patients should inform their doctor about any pre-existing medical conditions, especially active infections, before starting treatment. Storage instructions should be followed as per the manufacturer’s guidelines, typically requiring refrigeration.